ライフサイエンスコーパス: PBS

1 PBS can be used in the micromolar range, equivalent to a

2 PBS elution of DBS offers a sensitive and specific metho

3 than 100 pg/ml in diluted PBS buffer (0.01X PBS).

4 was performed using a mixed riboflavin 0.1% PBS solution followed by UVA irradiation.

5 s injection of either PBS (control, n = 10), PBS-primed ECFCs (ECFCPBS, n = 13), or erythropoietin-pr

6 cell voltage of +560 mV vs Ag/AgCl, in 100mM PBS pH 7.4 with the addition of 20mM of synthetic glucos

7 al activity after 6 weeks of storage in 0.1M PBS, pH 7.4 at 4 degrees C.

8 were stable for 6 weeks when stored in 0.1M PBS, pH 7.4 at 4 degrees C.

9 Ab-bound MTPs, stored at 4 degrees C in 0.1M PBS, pH 7.4, retained its biological activity for 8 week

10 dy-bound MTPs, stored at 4 degrees C in 0.1M PBS, were highly stable and did not show any significant

11 icromolar range, equivalent to about 0.1% 1x PBS (150 muM).

12 le binding and detection of PSA in pH 7.4 1x PBS solutions, whereas control experiments with proteins

13 concentration of explants equilibrated in 1x PBS was significantly (p < 0.05) lower than the bath chl

14 ingBlock phosphate buffer saline- Tween-20; (PBS-T20) blocking buffer was utilized to minimize nonspe

15 glucose in phosphate buffer solution (0.25M PBS, pH 7.0), with a linear range between 0 mM and 0.9mM

16 aline (PBS) containing 0.02% Tween 80; pH7.4 PBS containing 1.0% triethyl citrate (PBStc); and pH7.4

17 peptide LbL immunosensor was immersed into a PBS solution containing the non-specific Ab (anti-HCV fo

18 lative to Prochlorococcus spp., which lack a PBS.

19 We have previously shown that a PBS DNA-binding repressor complex contains ZFP809 and TR

20 d to monitor the annealing of tRNA(Trp) to a PBS-containing RSV RNA.

21 were assessed by intravital microscopy after PBS, IL-1beta, TNF-alpha, or recombinant Gal-3 treatment

22 including the developmental anticancer agent PBS-1086.

23 hours than HBSS mice treated with PFCE-air, PBS-O2, or PBS-air (P < .05).

24 ps) or air only (hereafter, the PFCE-air and PBS-air groups) gas mixtures.

25 es of IL-17A and compared with TGF-beta- and PBS-treated cells as positive and negative controls, res

26 Succinate, fumarate, and PBS have no effect on cell viability, regardless of cell

27 0%; hereafter referred to as the PFCE-O2 and PBS-O2 groups) or air only (hereafter, the PFCE-air and

28 -linking using glutaraldehyde of the OCP and PBS followed by liquid chromatography coupled to tandem

29 with PPCN+SDF-1, SDF-1 only, PPCN only, and PBS, respectively.

30 rkers of immune cells between GA-treated and PBS-treated (control) mice.

31 product upon reaction by Cys-SeH in aqueous PBS buffer by exhibiting a approximately 210-fold fluore

32 ng its selectivity toward Cys-SeH in aqueous PBS buffer, in bovine serum, and on the silica gel surfa

33 No difference was observed between PBS and succinate on (18)F-fluorocholine uptake in the t

34 polyadenylation (PolyA), and primer binding (PBS) elements, do not participate in intermolecular base

35 release of daunorubicin was observed in both PBS and excised vitreous (~75% and ~18%) from the physic

36 ng alpha-l-fucosidase concentrations in both PBS and human blood serum.

37 ble to detect ULBP2 at 16-18 pg/mL in 1% BSA-PBS and in 10-fold-diluted human serum.

38 nducted in phosphate buffered saline buffer (PBS) and approximately 25pg/ml for assays containing PBS

39 A/OVA) mice compared with OVA-sensitized but PBS-challenged (OVA/PBS) control mice.

40 PE dose was compared with change produced by PBS injection.

41 Cells were stimulated by PBS, NRG, hydrogel, or NRG-hydrogel (NRG-HG) and evaluat

42 C) treated with platinum-based chemotherapy (PBS).

43 (Pt) during screening in "clean" conditions (PBS), and no degradation in performance during the opera

44 ions under biologically relevant conditions (PBS buffer) and a complex ethanol/water mixture (tequila

45 approximately 25pg/ml for assays containing PBS spiked with fetal bovine serum.

46 conformation and in the corresponding (-)/(+)PBS duplex.

47 ASO (66 mg/kg/wk), lisinopril (100 mg/kg/d), PBS (control), or scrambled ASO (66 mg/kg/wk) for 10 wk,

48 mune responses after mCMV infection than did PBS-treated mice.

49 tion limit is less than 100 pg/ml in diluted PBS buffer (0.01X PBS).

50 sing Ebola glycoprotein suspended in diluted PBS buffer, human serum, and plasma.

51 P2, HCP3) and another capable of dissipating PBS excitation (HCP4).

52 Log DMW,PBS values above 5.5 are only experimentally feasible wi

53 phosphate buffered saline (PBS) medium (DMW,PBS) for 19 cationic surfactants.

54 factant species account for the observed DMW,PBS.

55 received an intravenous injection of either PBS (control, n = 10), PBS-primed ECFCs (ECFCPBS, n = 13

56 G uptake by muscle when compared with either PBS or fumarate, highlighting the effect of succinate on

57 sulin-treated group compared with the FIV(+)/PBS-treated group.

58 urrent densities as high as 560muAcm(-2) for PBS containing 100mM glucose at 0.45V vs. Ag/AgCl.

59 iosensor was found to be 0.994 and 0.997 for PBS and milk respectively.

60 good linearity of the calibration curves for PBS and lysate solutions at low Sur concentrations confi

61 good linearity in the range 0.3-10 ng/mL for PBS and 0.3-50 ng/mL for milk.

62 s from MOG-psigma1-treated EAE or Bregs from PBS-treated EAE mice did not resolve disease, whereas th

63 retinal cross sections, and optic nerve from PBS-treated eyes, SARM1 protein levels were increased in

64 postsynaptic sites compared with those from PBS-treated mice.

65 curves for several standard solutions (e.g. PBS, HEPES or deionized water).

66 h were fully protected by HA/MF59 but not HA/PBS immunization against intranasal challenge with the h

67 er compared with the N+UCBMC (P<0.05) and HI+PBS groups (P<0.01), while fewer newborn neurons and mor

68 s lower in the HI+UCBMC compared with the HI+PBS group (P<0.01) and the HI+cyclopamine+UCBMC group (P

69 hook-shaped anterior ascending branches (ie, PBS).

70 dimetric assays the RSD values were 9+/-5 in PBS and 12+/-6 in serum.

71 al (<30%) rapamycin release within 50days in PBS buffer.

72 DMP), solubilized in vehicle (5% Tween-80 in PBS); the placebo group received vehicle only.

73 c determination of hemoglobin is achieved in PBS buffer as well as in the whole blood sample.

74 ntation using 5mg/mL bovine serum albumin in PBS and nonspecific surface test shows the excellent spe

75 2O2, malondialdehyde, and a lysine analog in PBS at a physiological temperature, which resulted in M2

76 100 to 10(4) cells per 10 muL of bacteria in PBS, respectively.

77 ic profile of the binding does not change in PBS solution.

78 d the hydrodynamic size of the AgIONs-Chi in PBS remained below 200 nm.

79 ed glucose transport through the coatings in PBS media and this was considered to be a as a consequen

80 ion curves of %B/B0 vs. OTA concentration in PBS showed that half-inhibition occurred at 1.17 microg

81 ar with logarithmic BoNT/A concentrations in PBS, milk and human serum across a 0.27-268pgmL(-1) rang

82 at 37 degrees C for the peptide conjugate in PBS buffer.

83 essfully stabilize it against degradation in PBS (pH=7.4).

84 concentration down to 0.1mg/L is detected in PBS, tap water, deionized water, and bottled water.

85 shown to be fundamental for BSA detection in PBS in these dyes.

86 we investigate the effect of H2 dissolved in PBS in the concentration 0.5 ppm wt/vol, applied on rabb

87 centration range from 50mg/dL to 400mg/dL in PBS and whole blood at 37 degrees C (R>0.96).

88 omplement, and Ig regulation are enhanced in PBS-treated Nrf2 null gene profiles compared with those

89 posite coatings during prolonged exposure in PBS.

90 e electrode analytical response to fetuin in PBS samples, obtained by square wave voltammetry, exhibi

91 n reaction in the presence of CAO-NSs/GCE in PBS.

92 75 muW cm(-2) is obtained in 5 mM glucose in PBS, the highest to date under these conditions, providi

93 eficiency was associated with an increase in PBS- and allergen-driven IgE levels, while IgG1 and IgG2

94 lms maintained their structural integrity in PBS, and each film could be repeatedly loaded with drug

95 e) to deliver agents (methylene blue, MB, in PBS) into bovine AC.

96 this platform was 10 fg/mL and 100 fg/mL in PBS and human serum, respectively.

97 ction limit is calculated to be 0.1 ng/mL in PBS buffer with a linear range of 0-9.0 ng/mL.

98 etection limit was approximately 30cfu/mL in PBS buffer.

99 xons in KA-treated injected eyes, but not in PBS-treated eyes.

100 GCs and axons in KA-treated eyes, but not in PBS-treated eyes.

101 nner in D54-CR tumor-bearing mice but not in PBS-treated mice.

102 % is obtained compared to result obtained in PBS (phosphate buffered saline).

103 n PBS, and show that the results obtained in PBS run buffer are much closer to previously reported va

104 D) of 3+/-1 and 7+/-4 (all in percentage) in PBS and serum, respectively, meanwhile for impedimetric

105 The in vitro calibrations were performed in PBS (pH 5.6), applying a constant potential of +500 mV.

106 acid that can reversibly release a proton in PBS buffer (pH = 7.4) under visible light is reported.

107 ction (LOD) at 100 fg/mL (~3 fM) of f-PSA in PBS solutions.

108 and selectivity in the detection of f-PSA in PBS.

109 we soaked the SeLECT-Defense(TM) sealant in PBS for 2 mos at 37 degrees C and found that the biofilm

110 to the partial recovery of function seen in PBS-injected control rats.

111 n and its DNA aptamer, which was selected in PBS, and show that the results obtained in PBS run buffe

112 logP = 7.1) with no measurable solubility in PBS buffer.

113 molecule, biotinylated anti-streptavidin, in PBS.

114 dothelial cells (hESC-ECs) were suspended in PBS or Matrigel and kept at 4 degrees C.

115 laparotomy, induced delivery earlier than in PBS control groups (P < 0.01).

116 s fluorescent nucleoside when included in (-)PBS or (-)/(+)PBS duplex fully preserves their stability

117 After immersing into PBS for 7 days, the transmittance of the optimal constru

118 the injection of their ethanol solution into PBS produced monodisperse nanometer size assemblies.

119 coronary artery followed by intramyocardial PBS injections (control group), and LAD ligation followe

120 ermination of crystal structures of isolated PBS components, critical questions regarding the interac

121 HOPG at concentrations </=100 muM in 0.15 M PBS, pH 7.2, showed fast kinetics and only minor suscept

122 utomer is strongly favored in matched (-)/(+)PBS duplexes, while the relative emission of the H3 taut

123 was investigated in phosphate buffer medium (PBS) with various pH ranges and the electron transfer pr

124 66pg/mL to 666ng/mL in physiological medium (PBS).

125 Additionally, the arrangement of minor PBS components located inside the core cylinders is unkn

126 aded substantially in 1:1 acetonitrile:10 mM PBS, pH 7.4, at 37 degrees C, generating primarily o(LA)

127 Median age of PBS was 55-59 years and median OS was 108 months.

128 showing the insufficient buffer capacity of PBS to maintain a stable pH at the given conditions.

129 rmine clinicopathological characteristics of PBS and estimate their associations with overall surviva

130 rated clinicopathological characteristics of PBS in the US population and supports performing BCS if

131 tions are far from the isotonic condition of PBS ( approximately 150 mM) that is normally used with b

132 and 0.93, respectively) for the detection of PBS.

133 Hydrolysis dynamics of PBS, poly(butylene adipate), poly(lactic acid), and poly

134 of the assembly, structure, and function of PBS.

135 ae (RoL), we detected complete hydrolysis of PBS thin films at pH 5 and 40 degrees C that proceeded t

136 ection of thrombin but not with injection of PBS as a vehicle control, demonstrating the first aptame

137 ory mucus was washed out by the injection of PBS to mouse nasal cavity, the response of MOR161-2 to a

138 zed to receive intramyocardial injections of PBS control (n=10), circulating angiogenic cells (n=8),

139 sedated and small intraocular injections of PBS were made into one eye and either Abeta or gamma-sec

140 24 hours after intratracheal instillation of PBS or S. pneumoniae, and differentially expressed (DE)

141 KSHV) in a fingerprick volume (50 microL) of PBS, plasma, and artificial saliva samples for a broad r

142 Using offspring of PBS- or HDM-exposed mothers, the magnitude of HDM or Asp

143 Compared with offspring of PBS-exposed mothers, offspring of HDM-exposed mothers de

144 er marginal or absent in OVA-treated pups of PBS-exposed mice.

145 increase of the enzymatic hydrolysis rate of PBS than of nonpolymeric dibutyl adipate.

146 aluated the microchip with spiked samples of PBS with bacteria concentration between 10(1) to 10(8) C

147 ed with NA alone did not differ from that of PBS-administered controls.

148 When incorporated into the loop of (-)PBS, the (-)DNA copy of the HIV-1 primer binding site, b

149 ered saline (PBS) or the same volume of only PBS solution was injected into gingival tissue approxima

150 eived intratumoral injection of GLV-1h153 or PBS.

151 after intranasal challenges with allergen or PBS.

152 1)I ( approximately 5 mCi), (131)I alone, or PBS, and followed for tumor growth.

153 with 0.1% ethanol (control for RvD2) and/or PBS (control for LPS), and control microRNA mimics and i

154 ations of diesel exhaust particles (DEPs) or PBS.

155 A DMSO or PBS vehicle control was included for each experiment bas

156 lenged with house dust mite (HDM) extract or PBS five days per week for four weeks.

157 after intratumoral injection of fumarate or PBS.

158 njugated hydrogel (QHG213H), control gel, or PBS was injected into the peri-infarct/MI zone.

159 ice were treated either with 10 IU/ml hCG or PBS at days 0, 2, 4, and 6 of pregnancy.

160 ected intraperitoneally with anti-IgE mAb or PBS 6 hours before challenge with AP or saline.

161 ind limb blood flow compared with nitrate or PBS therapy.

162 HBSS mice treated with PFCE-air, PBS-O2, or PBS-air (P < .05).

163 -sensitized mice were challenged with OVA or PBS for 4 wk.

164 mice were vaccinated with wtMVA, MVA-OVA, or PBS, sensitized to OVA/alum and challenged with a diet c

165 how diet and were treated with anti-OX40L or PBS for 10 wk.

166 to PLY, PPSV23, a mixture of PPSV23/PLY, or PBS (mock).

167 24 h after instillation of S. pneumoniae or PBS.

168 Peptide in the tears or PBS delivery vehicle had the most significant reduction

169 et, we administered HJ6.3 (10 mg/kg/week) or PBS intraperitoneally to 7-month-old APP/PS1 mice for 21

170 nucleoside when included in (-)PBS or (-)/(+)PBS duplex fully preserves their stability and exhibits

171 with OVA-sensitized but PBS-challenged (OVA/PBS) control mice.

172 bsequent stability analysis in mobile phase, PBS buffer, and rat serum of 12 aryl sulfonyl chloride p

173 The phycobilisome (PBS) is an extremely large light-harvesting complex, com

174 ted OCP(r) interacts with the phycobilisome (PBS), the cyanobacterial antenna, and induces excitation

175 ssipation at the level of the phycobilisome (PBS), the cyanobacterial antenna, induced by the orange

176 rbed by the light-harvesting phycobilisomes (PBS) in cyanobacteria.

177 Control animals received PBS injection.

178 Transected rat MCLs received PBS or IL-1Ra at the time of surgery.

179 Control mice received PBS.

180 d challenge with ovalbumin (OVA) or received PBS.

181 rophils compared with control mice receiving PBS (p < 0.01; n = 8-11).

182 complex and show that EBP1 depletion reduces PBS-mediated retroviral silencing.

183 omer 5S,12S-diHETE is produced after saline (PBS) administration.

184 on was 0.29pg/ml in phosphate buffer saline (PBS) and 1.3pg/ml in mouse brain tissue homogenate, resp

185 inert media such as phosphate buffer saline (PBS), failing to account for the reactivity of media com

186 In a mixed solvent [phosphate buffer saline (PBS), pH = 7.4/ethanol 1:9], the fluorescence response o

187 f 5 mM glucose in phosphate-buffered saline (PBS) (50 mM phosphate buffer solution, pH 7.4, with 150

188 (experimental) or phosphate-buffered saline (PBS) (control).

189 room temperature phosphate-buffered saline (PBS) also caused significant alteration of protein phosp

190 nO surface in (i) phosphate buffered saline (PBS) and (ii) human serum.

191 t 3 days by using phosphate-buffered saline (PBS) and cysteine/methionine-free Dulbecco's Modified Ea

192 ection of cTnT in phosphate buffered saline (PBS) and human serum (HS) buffers was achieved at low sa

193 were obtained in phosphate-buffered saline (PBS) and in undiluted artificial urine at clinically rel

194 10(7) CFUs/mL in phosphate buffered saline (PBS) and peritoneal dialysis (PD) fluid.

195 usly with PFCE or phosphate-buffered saline (PBS) and then managed in either air/O2 (FiO2 proportion,

196 all compounds in phosphate-buffered saline (PBS) and urine samples owing to the large volume and cap

197 ric oxide (NO) in phosphate-buffered saline (PBS) at pH 7.4.

198 mast cells or 1x phosphate-buffered saline (PBS) before collecting serum, liver, and cholangiocytes.

199 wly degradable in phosphate buffered saline (PBS) but more rapidly degraded in the presence of a lipa

200 TFC and TCC than phosphate buffered saline (PBS) extracts for all the fruits parts.

201 0 mug of DNA plus phosphate-buffered saline (PBS) i.m. using a needleless Biojector device.

202 te, fumarate, and phosphate-buffered saline (PBS) in different cell models.

203 rus elution using phosphate-buffered saline (PBS) may provide an alternative analyte for lower-cost q

204 yer membranes and phosphate buffered saline (PBS) medium (DMW,PBS) for 19 cationic surfactants.

205 ation of SDF-1 in phosphate buffered saline (PBS) on wound healing was evaluated in a diabetic murine

206 ere injected with phosphate-buffered saline (PBS) or GBV-B, respectively.

207 TSG-6 in 5-microL phosphate-buffered saline (PBS) or the same volume of only PBS solution was injecte

208 IV-1 in serum and phosphate buffered saline (PBS) samples with viral loads ranging from 10(4) to 10(8

209 ature in 30min in phosphate buffered saline (PBS) solution.

210 rough dilution of phosphate-buffered saline (PBS) to tune Cdl to dominate the overall capacitance cha

211 mmol/L in 100 mM phosphate-buffered saline (PBS) without significant interference: high-density lipo

212 concentration for phosphate buffered saline (PBS), a typical ionic medium for biological samples, and

213 studied probes in phosphate-buffered saline (PBS), urine, and whole blood.

214 buffers, such as phosphate buffered saline (PBS).

215 d rate in aerated phosphate buffered saline (PBS).

216 n to be stable in phosphate buffered saline (PBS).

217 microparticles in phosphate-buffered saline (PBS).

218 IP-antagonist) or phosphate-buffered saline (PBS).

219 h air and flowing phosphate buffered saline (PBS).

220 ed batch systems: phosphate-buffered saline (PBS, oligotrophic) and basal culture medium (BCM, eutrop

221 nd lactic acid in phosphate buffered saline (PBS, pH7.4) and acetate buffer (AB, pH4.3), respectively

222 animals received phosphate-buffered saline (PBS; n = 5 to 7).

223 5.5, 6.5, and 7.4 phosphate buffered-saline (PBS) containing 0.02% Tween 80; pH7.4 PBS containing 1.0

224 cose-containing medium compared with saline (PBS).

225 nated with REG or phosphate-buffered saline [PBS]) after homologous or heterologous RSV challenge.

226 Primary breast sarcoma (PBS) is a rare and heterogeneous group of malignancies w

227 nificantly higher than that from GAPDH-siRNA PBS (p<0.05).

228 NAs and target the tRNA primer binding site (PBS) essential for ERV reverse transcription.

229 ional repressors to the primer binding site (PBS) of the provirus.

230 olyadenylation (polyA), primer-binding site (PBS), and Psi-packaging domains.

231 -stranded region of the primer binding site (PBS)-segment of the 5'-UTR.

232 the genomic RNA (gRNA) primer binding site (PBS).

233 NA copy of the HIV-1 primer binding site, (-)PBS, both in its stem loop conformation and in the corre

234 et of features from potential binding sites (PBSs) in the mRNA and then train a classifier to disting

235 rried out in 0.1M phosphate buffer solution (PBS) at pH 7.0 and 0.1M KCl solution at room temperature

236 Fe(CN)6(4-)) in a phosphate buffer solution (PBS) containing AFB1, the magnitude of anodic current at

237 e (GSH) in pH 7.2 phosphate buffer solution (PBS) has been reported.

238 AgCl) in a pH 6.5 phosphate buffer solution (PBS).

239 albumin (BSA) in phosphate buffer solution (PBS).

240 accomplished in a phosphate buffer solution (PBS, pH=7) for ZnO/MWCNT/GCE samples.

241 bodies (Ab) in phosphate buffered solutions (PBS).

242 ot survive, we used physiological solutions (PBS with 154 mM Na+) that are highly practical for pursu

243 lative to in vivo from 64%, using a standard PBS dissolution method, to 92%.

244 combination of population branch statistics (PBS) and number of segregating sites by length (nSL) to

245 n experiments with poly(butylene succinate) (PBS) and the lipase of Rhizopus oryzae (RoL), we detecte

246 cific ligand, or vehicle (dimethyl sulfoxide/PBS).

247 Prune Belly Syndrome (PBS) is a rare entity, usually found in male neonates.

248 ding was prevented using starting block T20 (PBS).

249 of four delivery vehicles: artificial tears, PBS, methylcellulose, and aquaphor cream.

250 Here we show that PBS-soluble phosphorylated high-molecular-weight (HMW) t

251 The PBS domain adopts a bent conformation resembling the sha

252 The PBS offers a unique target to specifically inhibit LTR-r

253 The PBS was found in 23 (62%) of 37 total patients with FCD2

254 lize the interaction between the OCP and the PBS.

255 utable to structure-dependent binding at the PBS-segment of the HIV-1 5'-UTR during virus assembly.

256 emand for NADPH and linear ETC declines, the PBS associates with photosystem I.

257 ecovery protein (FRP) detaches OCP1 from the PBS core, accelerating its back-conversion to OCP(O) ; b

258 ction limit of approximately 4.8pg/ml in the PBS buffer.

259 h in the NK92-treatment group but not in the PBS-treatment group.

260 ected by adding specific antibodies into the PBS buffer.

261 l domain of the OCP burrows tightly into the PBS while leaving the OCP C-terminal domain on the exter

262 photoactivated OCP bound to the core of the PBS affords almost total energy dissipation.

263 nt models of the general architecture of the PBS have been proposed, based on low resolution images f

264 cellent reproducibility and specificity, the PBS, when present, could become a useful qualitative dia

265 esponsible for annealing primer tRNAs to the PBS to initiate reverse transcription in retroviruses, b

266 residues of the OCP that cross-link with the PBS are situated in the linker region, between the N- an

267 to 2-fold) animal survival compared with the PBS-treated control group.

268 we identify specific interactions within the PBS subcomponents that enable us to suggest possible fun

269 (FRP), dislodges the active OCP(r) from the PBSs and accelerates its conversion to the inactive OCP.

270 However, they do not consider whether the PBSs are functional or not, and consequently result in h

271 These PBS-based temperature acclimation strategies may underli

272 ncement in penetration was found compared to PBS control.

273 sion (6.2-fold reduction in size compared to PBS-treated controls) and highest survival when treatmen

274 d within collagen gels over 72 h compared to PBS.

275 skin in vitro by 7.8+/-1.1-fold compared to PBS.

276 Pregnant female mice were exposed to PBS or HDM during pregnancy.

277 n Linux-based clusters running SLURM, Torque/PBS, or SGE.

278 A molecule to the U5 primer binding site (U5-PBS) region of the viral genome.

279 s multiple structured regions in both the U5-PBS and tRNA(Pro) primer that otherwise sequester residu

280 Our structures of NC bound to U5-PBS and tRNA(Pro) reveal the structure-based mechanism f

281 2 (mug/mL)(-1)] in comparison with undiluted PBS.

282 No previous KCE studies of DNA used PBS as the run buffer.

283 Here, we test the feasibility of using PBS as a KCE run buffer for analysis of DNA and show tha

284 o 4 weekly gavages with CpG/PN-NPs, vehicle (PBS), nanoparticles alone, peanut alone, CpG nanoparticl

285 following infusions of ANI, TTX, or vehicle (PBS).

286 received non-immunized colostrum or vehicle (PBS).

287 h injection repeated at week 3 (n=16) versus PBS control (n=16).

288 l/min per gram of dry weight, mean+/-SE) vs. PBS (1.6 +/- 0.34).

289 nctional intact Thermosynechococcus vulcanus PBS, as well as functional cross-linked adducts.

290 Human serum diluted 1:2 with PBS buffer was analyzed by LDL-MIP sensors to demonstrat

291 Allergen detection in 2D-Western blots with PBS resulted in greater sensitivity than with TBS or Tri

292 hNIS-expressing infected cells compared with PBS control.

293 visually cued navigation, when compared with PBS-treated animals.

294 attenuated cardiac remodeling compared with PBS-treated control animals.

295 AR-gamma in glia was increased compared with PBS-treated FIV(+) control animals.

296 female mice was similar (4.7 +/- 2.0 g with PBS treatment and 3.3 +/- 2.1 g with EPO treatment).

297 d via the hepatic artery, then perfused with PBS, followed by successive Triton X-100 and SDS solutio

298 , for 30 min and regenerated by shaking with PBS buffer, pH 7.2, at 4 degrees C overnight.

299 est that modifying the carrier solution with PBS, sucrose, and/or IPA would enable characterization a

300 P = 0.001) than control animals treated with PBS injections.